← back to search

Mira Stadler

German Cancer Research Center · DE
Area of research
Oncology · Epidemiology
Research interest
Research interests include Cancer Cells and Metastasis, 3D Printing in Biomedical Research, MicroRNA in disease regulation, and Hepatitis B Virus Studies.
h-index
12
citations
1,475
works
19
NIH funding
primary concept
email

Recent publications

Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD
Developmental Cell 2022cited by 64position: middledoi
SpaceM reveals metabolic states of single cells
Nature Methods 2021cited by 335position: middledoi
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
JHEP Reports 2021cited by 21position: middledoi
Oxygenation and miR138-5 p act as rheostats in APOBEC3B-mediated Hepatitis B Virus control
Zeitschrift für Gastroenterologie 2020cited by 0position: middledoi
Dysregulated epigenetic factors in non-alcoholic fatty liver disease and triggered liver cancer
Zeitschrift für Gastroenterologie 2019cited by 0position: middledoi
Identification of Molecular Mechanisms by which NASH-derived Inflammation alters Hepatic Lipid Metabolism
Zeitschrift für Gastroenterologie 2019cited by 0position: firstdoi
Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells
Scientific Reports 2018cited by 93position: firstdoi
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
Cancer Cell 2017cited by 195position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mathias Heikenwälder · German Cancer Research Center5 papers (2019–2022)Theodore Alexandrov · BioInnovation Institute3 papers (2019–2021)Kristian Unger · German Cancer Research Center2 papers (2020–2022)Tobias Riedl · Goethe University Frankfurt2 papers (2020–2022)Luca Rappez · Pacific Northwest National Laboratory2 papers (2019–2021) · 1 papers (2022–2022)Daniel B. Lipka · German Cancer Research Center1 papers (2020–2020) · 1 papers (2022–2022)Dominik Pfister · Novo Nordisk (Denmark)1 papers (2019–2019)Markus Hengstschläger · University of Dundee1 papers (2018–2018)Suzanne Faure‐Dupuy · Centre National de la Recherche Scientifique1 papers (2020–2020)Maximilian Schönung · German Cancer Research Center1 papers (2020–2020) · 1 papers (2022–2022)Florian Reisinger · The University of Melbourne1 papers (2020–2020) · 1 papers (2022–2022) · 1 papers (2022–2022)Jane A. McKeating · University of Birmingham1 papers (2020–2020)Martin Scherzer · Karolinska Institutet1 papers (2018–2018) · 1 papers (2022–2022)Rupert Öllinger · TUM Klinikum1 papers (2022–2022)